We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

71 hedge funds and large institutions have $114M invested in Gyre Therapeutics in 2013 Q2 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

81% less call options, than puts

Call options by funds: $1.26M | Put options by funds: $6.73M

Holders
71
Holders Change
+71
Holders Change %
–
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
71
Increased
–
Reduced
–
Closed
–
Calls
$1.26M
Puts
$6.73M
Net Calls
-$5.47M
Net Calls Change
-$5.47M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$26.4M +$29.8M +7,837 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$19.9M +$22.5M +5,914 New
NMC
3
NEA Management Company
Maryland
$19.5M +$22.1M +5,807 New
BIT
4
BlackRock Institutional Trust
California
$4.75M +$5.37M +1,412 New
BFA
5
BlackRock Fund Advisors
California
$4.53M +$5.13M +1,347 New
Franklin Resources
6
Franklin Resources
California
$4.37M +$4.94M +1,299 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$3.55M +$4.02M +1,057 New
Jennison Associates
8
Jennison Associates
New York
$2.97M +$3.36M +882 New
Wellington Management Group
9
Wellington Management Group
Massachusetts
$2.33M +$2.64M +694 New
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$2.1M +$2.37M +624 New
Deutsche Bank
11
Deutsche Bank
Germany
$2M +$2.26M +594 New
State Street
12
State Street
Massachusetts
$1.94M +$2.19M +576 New
Northern Trust
13
Northern Trust
Illinois
$1.65M +$1.86M +490 New
JRJ
14
Jeffrey R. Jay
$1.57M +$1.78M +467 New
Millennium Management
15
Millennium Management
New York
$1.44M +$1.62M +427 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$1.43M +$1.61M +424 New
Renaissance Technologies
17
Renaissance Technologies
New York
$1.14M +$1.29M +339 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$774K +$875K +230 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$675K +$765K +201 New
Two Sigma Investments
20
Two Sigma Investments
New York
$642K +$727K +191 New
RFC
21
Russell Frank Company
Washington
$616K +$696K +183 New
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$587K +$666K +175 New
TCIM
23
TIAA CREF Investment Management
New York
$567K +$643K +169 New
CCMH
24
Cornerstone Capital Management Holdings
New York
$566K +$639K +168 New
Goldman Sachs
25
Goldman Sachs
New York
$542K +$613K +161 New
1
2 3

GYRE Hedge Fund Activity: Q2 2013 in Review

71 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q2 2013, worth a combined $114M.

Buyers outnumbered sellers: 71 funds opened new GYRE positions and 0 closed out — a net gain of 71 holders — while 0 added to existing stakes and 0 trimmed.

  • 71 institutional investors held Gyre Therapeutics (GYRE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $114M of Gyre Therapeutics stock for Q2 2013.
  • 71 funds opened new Gyre Therapeutics positions in Q2 2013 and 0 closed out, a net change of +71 holders.

Based on aggregated 13F filings for Q2 2013.